FDA Moving to Authorize Pfizer-BioNTech Booster for 16-, 17-Year-Olds

FDA Moving to Authorize Pfizer-BioNTech Booster for 16-, 17-Year-Olds
·3 min read

The agency could authorize Covid-19 boosters as soon as next week as concerns rise over a new, possibly more transmissible variant.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting